Global fill finish manufacturing market is anticipated to grow at a CAGR of 15.1% during the forecast period (2024-2031). The market growth is attributed to the growing use of pre-filled syringes for parenteral dosages, growing demand for vaccines and biologics, and increasing pharmaceutical and biotechnology applications globally driving the growth of the market. The demand for fill-finish capabilities is growing owing to several factors, such as larger drug development pipelines, a shift toward more complex medications (primarily the rise in biologics), the need for flexibility during the manufacturing process, and stricter regulatory requirements.
Browse the full report description of “Fill Finish Manufacturing Market Size, Share & Trends Analysis Report by Product (Vials, Prefilled Syringes, Cartridges and Other), and by End-Users (Pharmaceutical & Biotechnology Companies and Contract Manufacturing Organizations) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/fill-finish-manufacturing-market
The increasing strategic investment expands the BPS manufacturing footprint and adds state-of-the-art equipment designed to help products achieve stability and improved shelf life through lyophilization (freeze drying). It also adds an aseptic syringe filling line, enabling BPS to meet the growing demand for this delivery platform in both Europe and the US. For instance, in November 2021, Baxter International Inc. announced a $100.0 million investment in BioPharma Solutions Halle/Westfalen, Germany sterile fill/finish manufacturing facility. This facility is operated by BioPharma Solutions (BPS), a business unit of Baxter that specializes in partnering with pharmaceutical and biotech companies on the development and contract manufacturing of drug products for parenteral (injectable) pharmaceuticals.
For filled vials, syringes, cartridges, and other medical-grade items, fill and finish processes are necessary to ensure that the appropriate amount of sterile and contamination-free products are added and sealed consistently. Market players expanding commercial filling lines to efficiently boost the capacity of aseptic manufacture for a global clientele. For instance, in October 2023, Vetter Pharma-Fertigung GmbH & Co. KG announced an investment of €230.0 million ($248.9 million) in several new commercial filling lines to effectively increase aseptic manufacturing capacity for the global customer base. The expansion of filling capacity through new commercial production lines at other sites in the EU, the expansion in cool storage and warehousing, as well as a new technical equipment warehouse.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Product
o By End-Users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- AbbVie Inc., Baxter International Inc., Becton, Dickinson and Company (BD), Novartis AG, Pfizer Inc., among others.
Key questions addressed by the report.
Global Fill Finish Manufacturing Market Report Segment
By Product
By End-Users
Global Fill Finish Manufacturing Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fill-finish-manufacturing-market